3.28% -0.4021

Nyxoah Sa (NYXH)

Überblick Nachrichten Preisverlauf Forum Prognose

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Nyxoah Sa Stock (NYXH) Company Profile

Healthcare (1233)

Nächster Verdiensttermin

Neueste SEC-Einreichungen

NYXH's Discussions on Twitter

Vergleichen Sie NYXH mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
NYXH Nyxoah Sa	9.43	352.94M	4.71M	-46.77M	-60.34M	-1.6792
ISRG Intuitive Surgical Inc	546.16	193.26B	7.87B	2.24B	586.00M	6.22
BDX Becton Dickinson Co	235.58	68.18B	20.18B	1.71B	3.07B	5.94
ALC Alcon Inc	83.76	41.56B	9.76B	1.16B	665.00M	2.34
RMD Resmed Inc	234.62	34.52B	4.81B	1.11B	1.35B	7.55
WST West Pharmaceutical Services Inc	334.56	24.14B	2.88B	499.60M	321.60M	6.74

Nyxoah Sa Stock (NYXH) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2023-07-31	Eingeleitet	H.C. Wainwright	Buy
2023-07-19	Eingeleitet	Robert W. Baird	Neutral
2022-04-21	Eingeleitet	Oppenheimer	Outperform
2022-04-06	Eingeleitet	Wolfe Research	Peer Perform
2021-12-21	Fortgesetzt	Cantor Fitzgerald	Overweight
2021-07-28	Eingeleitet	Cantor Fitzgerald	Overweight

Alle ansehen

Nyxoah Sa Aktie (NYXH) Neueste Nachrichten

Finanzdaten der Nyxoah Sa-Aktie (NYXH)

Nyxoah Sa (NYXH)

Nyxoah Sa Stock (NYXH) Company Profile

Vergleichen Sie NYXH mit anderen Aktien

Nyxoah Sa Stock (NYXH) Upgrades & Downgrades

Nyxoah Sa Aktie (NYXH) Neueste Nachrichten

Retail investors are Nyxoah S.A.'s (EBR:NYXH) biggest owners and were rewarded after market cap rose by €38m last week - Simply Wall St

Nyxoah (NASDAQ:NYXH) Stock Price Up 1.2% – Here’s What Happened - Defense World

Nyxoah Receives Transparency Notification from BlackRock, Inc. - TipRanks

Nyxoah: The Future Of OSA (NASDAQ:NYXH) - Seeking Alpha

How the (NYXH) price action is used to our Advantage - Stock Traders Daily

Publication relating to transparency notifications - GlobeNewswire

BlackRock Takes 3% Stake in Medical Device Maker Nyxoah in Strategic Investment Move - StockTitan

Invitation to attend the special shareholders’ meeting of the Company to be held on December 19, 2024 - Finansavisen

(NYXH) Investment Analysis and Advice - Stock Traders Daily

Nyxoah's SWOT analysis: sleep apnea innovator faces growth hurdles - Investing.com

Nyxoah's SWOT analysis: sleep apnea innovator faces growth hurdles By Investing.com - Investing.com UK

Nyxoah's nerve stimulation device meets endpoints in sleep apnoea studyMedical Device Network - Oficjalny Portal Gminy Brzesko

HC Wainwright Reaffirms “Buy” Rating for Nyxoah (NASDAQ:NYXH) - Defense World

Nyxoah’s Genio Neurostimulator for OSA Launches in England - Sleep Review

Nyxoah's SWOT analysis: sleep apnea innovator's stock poised for US launch - Investing.com

Nyxoah Launches Revolutionary Sleep Apnea Treatment in England with First NHS-Covered Implants - StockTitan

Nyxoah Announces Commercial Launch of Genio® Innovative Therapy in England - GlobeNewswire

Nyxoah Announces Commercial Launch of Genio Innovative Therapy in England - Marketscreener.com

Where are the Opportunities in (NYXH) - Stock Traders Daily

Nyxoah Updates Share Capital and Voting Rights - TipRanks

Information on the Total Number of Voting Rights And Shares: Nyxoah - The Korea Bizwire

Information on the total number of voting rights and shares - GlobeNewswire

Objective long/short (NYXH) Report - Stock Traders Daily

Nyxoah (NASDAQ:NYXH) vs. Alpha Tau Medical (NASDAQ:DRTS) Head to Head Contrast - Defense World

Nyxoah to Participate in the Piper Sandler 36th Annual Healthcare Conference - The Korea Bizwire

Nyxoah to Present at Healthcare Conference Amidst Growth - TipRanks

Nyxoah to Present Sleep Apnea Innovation at Piper Sandler Healthcare Conference | NYXH Stock News - StockTitan

Nyxoah SA (NYXH) Reports Q3 Loss, Tops Revenue Estimates - MSN

Invitation to attend the special shareholders’ meeting of the Company to be held on December 19, 2024: Nyxoah - The Korea Bizwire

Nyxoah Schedules Special Meeting to Vote on EIB Loan Agreement Terms | NYXH Stock News - StockTitan

Publication Relating to Transparency Notifications: Nyxoah - The Korea Bizwire

Nyxoah’s Voting Rights Shift with ResMed Stake - TipRanks

ResMed's Stake in Nyxoah Drops Below 5% Threshold in Latest Holdings Update | NYXH Stock News - StockTitan

Publication relating to transparency notifications, Business Wires News - AsiaOne

Nyxoah S.A. (NASDAQ:NYXH) Short Interest Down 17.4% in October - MarketBeat

Nyxoah's SWOT analysis: sleep apnea device maker's stock poised for growth - Investing.com India

Nyxoah Third Quarter 2024 Earnings: €0.50 loss per share (vs €0.27 loss in 3Q 2023) - Simply Wall St

Nyxoah Reports Third Quarter Financial and Operating Results - Wahanariau

Nyxoah sales jump 30% to €1.3 million in Q3 2024 - Medical Buyer

Nyxoah SA Reports Growth Amid Clinical Advances - TipRanks

EQS-News: Nyxoah Reports Third Quarter Financial and Operating Results - sharewise

Nyxoah Eyes Strong US Launch Amid Financial Growth - TipRanks

Nyxoah S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nyxoah Reports Third Quarter Financial and Operating Results, Business Wires News - AsiaOne

(NYXH) Investment Report - Stock Traders Daily

Nyxoah Q3 Revenue Surges 30% as FDA Approval Timeline Stays on Track for 2025 - StockTitan

Nyxoah SA (NYXH) Q3 2024: Everything You Need To Know Ahead Of Earnings - Yahoo Finance

Nyxoah SA Announces CFO Changes - Marketscreener.com

Nyxoah participates in a conference call with Cantor Fitzgerald - TipRanks

Nyxoah Appoints John Landry as Chief Financial Officer - The Manila Times

Nyxoah SA (NYXH) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release - MSN

Finanzdaten der Nyxoah Sa-Aktie (NYXH)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie NYXH